Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00570 TRAD CHI MED
RTNominal unchange4.310 0.000 (0.000%)
Others

28/12/2017 10:34

Trad Chi Med (00570) awarded TCM granules supply contract

[ET Net News Agency, 28 December 2017] China Traditional Chinese Medicine (00570) said
its 87.3% owned subsidiary Jiangyin Tianjiang Pharmaceutical Co., Ltd has been awarded
through tender process a supply contract of concentrated TCM granules with Hong Kong
Hospital Authority (HKHA).
The supply contract shall cover a two-year period from 1 April 2018 to 31 March 2020,
during which Jiangyin Tianjiang shall supply over 400 types of concentrated TCM granules
for prescriptions to 18 Chinese traditional medicinal clinics under the management of
HKHA. (HL)

Back to Others

Remark: Real time quote last updated: 19/04/2024 15:09
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.